- 1Center for Immunity and Inflammation, New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, NJ, USA
- 2Graduate School of Biomedical Sciences, New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, NJ, USA
- 3Department of Pediatrics, New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, NJ, USA
Mycotic infections and their effect on the human condition have been widely overlooked and poorly surveilled by many health organizations even though mortality rates have increased in recent years. The increased usage of immunosuppressive and myeloablative therapies for the treatment of malignant as well as non-malignant diseases has contributed significantly to the increased incidence of fungal infections. Invasive fungal infections have been found to be responsible for at least 1.5 million deaths worldwide. About 90% of these deaths can be attributed to Cryptococcus, Candida, Aspergillus, and Pneumocystis. A better understanding of how the host immune system contains fungal infection is likely to facilitate the development of much needed novel antifungal therapies. Innate cells are responsible for the rapid recognition and containment of fungal infections and have been found to play essential roles in defense against multiple fungal pathogens. In this review we summarize our current understanding of host-fungi interactions with a focus on mechanisms of innate cell-mediated recognition and control of pulmonary aspergillosis.
Introduction
Immunocompromised individuals comprise a growing population in today's world. In part, this is due to the increased use of immunosuppressive drugs as therapies for diverse disease states. Thus, a variety of patients are increasingly more susceptible to develop invasive fungal infections. Aspergillus fumigatus is the etiological agent of over 90% of the invasive aspergillosis (IA) cases and it is considered the most common inhaled fungal pathogen (Dixon et al., 1996; Hohl and Feldmesser, 2007; Lehrnbecher et al., 2010). Even with diagnosis and treatment, individuals suffering from IA rarely recover. Exposure to A. fumigatus spores is a daily event, and for most individuals exposure to this environmental fungus is without consequence (Ben-Ami et al., 2010). Immune responses to A. fumigatus are central in preventing IA, and are likely responsible for the absence of disease manifestations in people with an intact immune system. Several recent reviews have detailed the important contributions of adaptive immunity to antifungal defense (Wuthrich et al., 2012a; Rivera, 2014; Verma et al., 2015). In this review we will focus our discussion on the recognition of the pathogen, the role of the innate immune system in response to respiratory fungal infection, and how diverse innate cell populations orchestrate antifungal defense against A. fumigatus.
Aspergillus fumigatus and Related Diseases
Aspergillus fumigatus is regarded as one of the most prevalent airborne fungal pathogens capable of causing severe to fatal invasive infections in immunocompromised individuals (Dixon et al., 1996; Hohl and Feldmesser, 2007; Lehrnbecher et al., 2010). Once inhaled, the conidia of A. fumigatus are small enough (2–3 microns) to enter the terminal respiratory airways, and reach the pulmonary alveoli (Ben-Ami et al., 2010). It is estimated that humans inhale several conidia per day, which are efficiently cleared by the pulmonary innate immune system (Margalit and Kavanagh, 2015). If not, they will germinate into hyphal structures, which can damage lung tissue (Dagenais and Keller, 2009). The innate immune system is the first line of defense against metabolically active and swelling conidia. Important innate cells in defense against aspergillosis include macrophages, neutrophils, monocytes and dendritic cells (Margalit and Kavanagh, 2015) (Table 1).
One of the most deleterious complications that can affect an immunocompromised individual is invasive aspergillosis (IA; Hohl and Feldmesser, 2007). Examples of susceptible immunocompromised patients include: those who are undergoing chemotherapy for acute leukemia, recipients of allogeneic haematopoietic stem cell transplants as well as solid-organ transplants, those under corticosteroid treatment for graft-vs.-host disease (GVHD), patients with aplastic anemias and prolonged neutropenia, patients that suffer from neutrophil defects such as chronic granulomatous disease (CGD), and patients suffering from advanced human immunodeficiency virus disease (HIV; Ben-Ami et al., 2010). Infection occurs primarily in the lungs of the patients, but dissemination to practically every organ can occur in the most severe of cases (Segal, 2009).
Some of the most prominent characteristics of IA include: filamentous growth in the pulmonary parenchyma, angioinvasion, intravascular thrombosis, tissue infarction, and haematogenous dissemination (Ben-Ami et al., 2010). Dissemination of aspergillosis to the central nervous system is a devastating effect of IA, which is characterized by the onset of seizures as well as other focal neurologic signs (Segal, 2009). IA has been found to be a leading cause of death among hematology patients (Latge, 1999). It is estimated to occur in 5–25% of acute leukemia patients, 5–10% after allogeneic bone marrow transplantation, and 0.5–5% after cytotoxic treatment of blood diseases as well as solid-organ transplantation (Latge, 1999). IA is also considered to be the main fungal infection found in cancer patients (Bodey et al., 1992; Wald et al., 1997; Kaiser et al., 1998; Lehrnbecher et al., 2010). The average incidences described are probably underestimations of the actual number of incidences since the diagnostic tests available are of low sensitivity (Bodey et al., 1992; Wald et al., 1997; Kaiser et al., 1998; Lehrnbecher et al., 2010; Brown et al., 2012).
A. fumigatus has also been shown to cause other diseases such as allergic bronchopulmonaryaspergillosis (ABPA) and aspergillomas (Latge, 1999). ABPA is the most severe allergic complication, (Latge, 1999) and it usually occurs in patients suffering from atopic asthma (1–2% develop ABPA) or cystic fibrosis (7–35% develop ABPA; Knutsen and Slavin, 1992; Moss, 2002). The disease manifests itself as a bronchial asthma that has transient pulmonary infiltrates, which may lead to proximal bronchiectasis and lung fibrosis (Cockrill and Hales, 1999; Moss, 2005). In the most severe of cases, ABPA can lead to respiratory failure and the fatal destruction of the infected lung (Knutsen et al., 2002; Moss, 2002, 2005). Aspergilloma, on the other hand, has been shown to occur in the preexisting lung cavities that have been caused by various lung disorders such as tuberculosis and sarcoidosis (Kirsten et al., 1992; Fujimura et al., 1998). Aspergilloma is characterized by a spheroid mass of hyphae that is embedded within a proteinaceous matrix in the external lining of the cavity (Latge, 1999).
Recognition of Aspergillus fumigatus by Innate Cell Receptors
C-Type Lectin Receptors (Dectin-1 and Dectin-2)
Upon inhalation, conidia mature and begin to swell, which leads to the loss of their RodA hydrophobic layer exposing the β-glucans in their cell wall (Aimanianda et al., 2009). β-glucans are recognized by the C-Lectin receptor, Dectin-1 (Hohl et al., 2005; Werner et al., 2009). Dectin-1 is expressed on macrophages, neutrophils, and dendritic cells (Werner et al., 2009). In vitro, it has been shown that Dectin-1 dependent alveolar macrophage production of cytokine and chemokines does not depend on the phagocytosis of the conidia, but on its morphology (Luther et al., 2007). Dectin-1 has been shown to be activated only in the presence of swollen, but not resting conidia (Gersuk et al., 2006; Aimanianda et al., 2009). Dectin-1 signals through Syk kinase, leads to the activation of NFκB, and the production of tumor necrosis factor (TNFα), IL-10, IL-6, IL-1α, granulocyte macrophage colony stimulating factor (GM-CSF), macrophage inflammatory protein α and β (MIP-1α, and MIP-1β; Hohl et al., 2005; Steele et al., 2005; Faro-Trindade et al., 2012). Dectin-1 has also been shown to have an important role in neutrophil recruitment (Werner et al., 2009). In Dectin-1 deficient mice, defects in neutrophil recruitment were due to unresponsive alveolar macrophages that were unable to produce chemoattractants (Werner et al., 2009).
Dectin-2, in contrast, recognizes α-mannans, which are found in the outer layer of the cell wall (Levitz, 2010; Sun et al., 2014). Dectin-2 has been shown to be mainly expressed on macrophages as well as dendritic cells (Sun et al., 2014). Detection of swollen conidia leads to the production of IL-1β, IL-10, IL-23p19, and TNFα via NFκB mediated by Syk (Sun et al., 2013, 2014). Blocking of Dectin-2 and Syk results in reduced conidial killing in macrophages differentiated from a human monocytic cell line (Sun et al., 2014).
Toll-Like Receptors (TLRs)
Toll-like receptors (TLRs) are membrane receptors that have a leucine-rich extracellular domain that recognizes pathogen-associated molecular patterns (PAMPs) as well as an intracellular Toll/interleukin-1 receptor (TIR) domain needed for downstream signaling (Kawai and Akira, 2007). Once TLRs recognize the pathogen, the signaling cascade leads to the activation of NFκB and other transcription factors, which leads to cytokine and chemokine production (Kawai and Akira, 2007).
TLRs have been found to play important roles in recognition of A. fumigatus for host defense although there is conflicting data, which could be attributed to differences in experimental design (Steele et al., 2005). They are primarily expressed on the cell surface of monocytes, macrophages, and dendritic cells (Takeda and Akira, 2005). TLR1−∕− murine bone marrow-derived macrophages had reduced amounts of IL-6, TNFα, CXCL2, and IL-12p40 in response to A. fumigatus conidia (Rubino et al., 2012). Cytokine production was diminished in TLR2−∕−, TLR4−∕− and TLR6−∕− macrophages, but not in TLR3−∕− or wild-type macrophages. In terms of survival, TLR1−∕−, TLR2−∕−, TLR4−∕−, and TLR6−∕− have been shown to be non-essential, and do not make immunocompetent mice more susceptible to A. fumigatus infection (Dubourdeau et al., 2006; Rubino et al., 2012). In another study performed in vitro, TLR2−∕− murine alveolar macrophages (AMs) infected with A. fumigatus were found to have an impaired inflammatory response due to their deficiency in TNFα production (Steele et al., 2005). Because AMs were still able to produce some detectable TNFα, TLR2 was determined to be non-essential for TNFα production, but necessary for Dectin-1 mediated production of TNFα (Steele et al., 2005). When AMs were treated with Dectin-1 blocking antibody, there was an observed 80% decrease in cytokine production, which was consistent in both TLR2−∕− and wild-type AMs (Steele et al., 2005). In addition, TLR2−∕−TLR4-/- mice, were found to have deficiencies in neutrophil recruitment compared to the single knockouts indicating that both receptors are required for an optimal immune response (Meier et al., 2003). TLR2 and TLR4 signaling requires the adaptor MyD88 adapter-like (Mal)/TIRAP in the myeloid differentiation primary response gene 88 (MyD88) dependent pathway (Horng et al., 2002). TLR4, on the other hand, can signal through another adaptor molecule, TIR-domain-containing adapter-inducing interferon-β (TRIF)-related adapter molecule (TRAM/TICAM-2), in the MyD88 independent pathway (Yamamoto et al., 2003).
In contrast to previous studies (Meier et al., 2003; Bellocchio et al., 2004; Rubino et al., 2012), other work has recently implicated a role for TLR3−∕− in A. fumigatus infection. TLR3−/− mice were observed to have deficiencies in dendritic cell (DC) migration to the lymph node, which affected their ability to prime T cells (Carvalho et al., 2012). Consistent with this finding, TLR3−∕− mice lacked the ability to produce a CD8+ T cell response in response to A. fumigatus infection (Carvalho et al., 2012). TLR3 as well as TLR4 can signal through the adaptor protein TRIF (Kawai and Akira, 2007), and TRIF−∕− mice displayed sustained inflammatory cell recruitment to the lungs in comparison to MyD88−∕− and wild-type mice that were chemically immunocompromised to serve as models of IA (de Luca et al., 2010). In addition, TLR3-expressing lung epithelial cells were shown to activate indoleamine 2,3-dioxygenase, which is an interferon (IFN)- inducible enzyme that degrades the amino acid tryptophan and suppresses adaptive T cell immunity (de Luca et al., 2010).
TLR9 is expressed on a variety of cells such as macrophages and monocytes (Ramirez-Ortiz et al., 2008). During phagocytosis of A. fumigatus, TLR9 recognizes the exposed and unmethylated CpG DNA (Ramirez-Ortiz et al., 2008). TLR9−∕− neutropenic mice exhibited a decreased inflammatory response compared to wild-type 2 days post infection, but was significantly increased 4 days post infection indicating an immunoregulatory role for TLR9 in A. fumigatus infection (Ramaprakash et al., 2009). Dectin-1 expression was also found to be decreased in TLR9−∕− mice, which could explain why there is a delayed immune response since Dectin-1 is important for recognition of A. fumigatus swollen conidia (Ramaprakash et al., 2009).
Myeloid Differentiation Primary Response Gene 88 (MyD88)
MyD88, the universal adapter through which all TLRs except TLR3 signal, has been shown to play an important role early in the inflammatory response against A. fumigatus (Ramaprakash et al., 2009). MyD88−∕− mice were shown to have delayed fungal clearance for the first 2 days, but were comparable to wild-type mice at about 3 days (Bretz et al., 2008). Early on, MyD88−∕− lungs appeared to have more necrotic tissue, and using a fluorescent A. fumigatus strain, a deficiency in macrophage uptake was observed (Bretz et al., 2008). Also, there was decreased cytokine production of interleukin (IL)-1β, IL-6, keratinocyte-derived chemokine (KC/CXCL1), IFNγ, but increased amounts of TNFα and MIP-1α in MyD88−∕− mice (Bretz et al., 2008). The normalization observed at day three indicates that there are alternative pathways involved in fungal clearance that are MyD88 independent (Margalit and Kavanagh, 2015). Recent studies further suggest that MyD88 signaling in defense against IA is crucially active on lung epithelial cells and is required for optimal production of neutrophil-recruiting chemokines (Jhingran et al., 2015).
Innate Cell Subsets and their Roles in Defense Against Aspergillosis
Epithelial Cells
The airway epithelium is the first point of contact for fungal spores upon inhalation, which leads to the initiation of the innate immune response (Figure 1; Paris et al., 1997). The respiratory epithelium consists of a variety of cell types such as mucous-secreting goblet cells, ciliated cells, and most importantly, respiratory epithelial cells (Paris et al., 1997). Respiratory epithelial cells release a broad range of antimicrobial peptides such as lactoferrin, chitinase, and β-defensins (Alekseeva et al., 2009; Balloy and Chignard, 2009). The tracheobronchial epithelial cells, Type II alveolar epithelial cells, and endothelial cells have been shown to have the ability to internalize conidia, which are then trafficked to late endosomes for processing (Paris et al., 1997; Filler and Sheppard, 2006). In comparison to other phagocytosing cells such as macrophages and neutrophils, epithelial cells are less efficient in fungal elimination (Wasylnka and Moore, 2003). Respiratory epithelial cells also express recognition receptors such as CLRs and TLRs (Sun et al., 2012). Upon challenge of the human bronchial epithelial cell line with swollen A. fumigatus conidia, Dectin-1 expression was induced in a TLR2-dependent manner, which induced the expression of ROS as well as TNFα, GM-CSF, IL-8, and the β-defensins HBD2 and HBD9 (Balloy et al., 2008; Sun et al., 2012). Dectin-1 blockade inhibited the expression of these factors indicating that airway epithelial cells require Dectin-1 for the upregulation of pro-inflammatory cytokines as well as antimicrobial factors (Sun et al., 2012).
Figure 1. Inhalation of Aspergillus fumigatus (A. fumigatus) conidia leads to the initial recognition of infection by lung epithelial cells and tissue-resident innate cells including alveolar macrophages and dendritic cells. This immediate response results in the production of chemokines that promote the rapid recruitment of neutrophils followed by the subsequent arrival of monocytes, pDCs, mast cells, eosinophils and NK cells. All of these innate cells cooperate in the elimination of fungal conidia by producing a combination of cytokines and protective factors. ROS, reactive oxygen species; NETs, neutrophil extracellular traps; TNF, tumor necrosis factor; IFN, interferon; pDCs, plasmacytoid dendritic cells. We would like to thank Servier Medical Art (http://www.servier.com) for figure graphics of immune cells.
Alveolar Macrophages (AM)
Alveolar macrophages have been shown to uptake as well as kill conidia through two known mechanisms: Reactive oxygen species (ROS) generation and phagosomal acidification (Ibrahim-Granet et al., 2003; Philippe et al., 2003). ROS generation occurs in response to swollen but not resting conidia, which leads to the recruitment of cytosolic proteins (p47phox, p67phox, p40phox, and Rac1/Rac2 GTPase) to the plasma membrane where they form a complex with membrane-bound flavocytochrome units, gp91phox and gp22phox, in order to form an active nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Forman and Torres, 2002; Gersuk et al., 2006). In immunosuppressed mice through cyclophosphamide treatment, mice were found to be less susceptible to IA than p47phox deficient mice, which are defective in NADPH ROS generation and a model of CGD. In addition, mice transgenic for p47phox under the control of the human CD68 that allows for targeted NADPH oxidase expression on macrophages and monocytes had increased survival rates compared to the global knockout illustrating the importance of oxidative mechanisms (Grimm et al., 2013). Specifically in AMs, p47phox deficient AMs were unable to control the growth of phagocytosed conidia in contrast to wild-type AMs (Grimm et al., 2013).
AMs play an important role in the inflammatory response through the activation of PRRs and cytokine and chemokine production (Figure 1), which include neutrophil attractants such as macrophage inflammatory protein-2 (MIP-2/CXCL2) and CXCL1(Bhatia et al., 2011). During phagosomal acidification, a phagosome containing conidia fuses with a lysosome in order to form a phagolysosome, which leads to ATPase mediated acidification and activation of enzymes such as chitinases that leads to the degradation of the cell wall exposing ligands for pattern recognition receptors (PRR), TLRs, and Dectin-1 (Ibrahim-Granet et al., 2003; Kasperkovitz et al., 2010; Faro-Trindade et al., 2012).
In vivo, clodronate treatment has been used as a method of depletion of AMs (Philippe et al., 2003; Bhatia et al., 2011). Clodronate treated mice were shown to have higher fungal burdens than wild-type mice even though there was an increase in neutrophil recruitment, which can indicate that there is some form of communication between AMs and neutrophils since both seem to be needed in order to control the infection (Bhatia et al., 2011). The mechanism by which this occurs has yet to be fully elucidated and warrants further study. It has been suggested that AMs are able to eliminate low amounts of inocula, and that higher amounts warrant neutrophil activation and recruitment (Philippe et al., 2003). These findings are controversial since there is also evidence that AMs are dispensable in A. fumigatus infection, which could be attributed to their use of different strains of mice as well as their use of diverse strains of A. fumigatus (Mircescu et al., 2009).
Neutrophils
A. fumigatus also produces immunosuppressive toxins such as gliotoxin and fumagillin, which affects neutrophil function by preventing the formation of a functional NADPH oxidase (Tsunawaki et al., 2004; Fallon et al., 2010). In a mutant strain of A. fumigatus in which the gliP gene is deleted, infected immunosuppressed mice through corticosteroid treatment had an attenuated virulence compared to non-immunosuppressed mice (Sugui et al., 2007). GliP catalyzes the first biosynthetic step in the synthesis of gliotoxin, and deletion prevents its synthesis as well as its effect on NADPH oxidase (Sugui et al., 2007). Neutrophils were found to be a primary target for gliotoxin since neutropenic mice did not differ in virulence when infected with the mutant compared to wild-type A. fumigatus (Spikes et al., 2008).
During neutrophil degranulation, azurophil granules expel fungicidal hydrolytic enzymes into the phagocytic vacuole (Segal, 2005). There are two predominant types of granules present in neutrophils: azurophil (primary) granules and specific (secondary) granules (Spitznagel, 1990; Segal, 2005). As mentioned, azurophils contain hydrolytic enzymes for killing and digestion of pathogens whereas specific granules serve as sources of replenishment for membrane components as well as limiting free radical reactions (Segal, 2005). Azurophil granules contain myeloperoxidase, cathepsin G, elastase, and proteinase 3 (Segal, 2005). Specific granules contain lactoferrin (binds and sequesters iron and copper), transcobalamin II, neutrophil gelatinase-associated lipocalin, and other membrane-associated proteins including flavocytochrome b558 of the NADPH oxidase (Segal and Jones, 1979; Segal, 2005). NADPH oxidase derived ROS has been shown to promote degranulation and activation of these hydrolytic enzymes (Reeves et al., 2002; Feldmesser, 2006). Activation leads to an accumulation of ROS into the endocytic vacuole, which leads to the accumulation of potassium ions in the vacuole to compensate for the anionic charge from ROS (Reeves et al., 2002). The increase in ionic strength triggers the release of the granule proteins (Reeves et al., 2002). The importance of these granules is demonstrated in mice deficient in the serine protease cathepsin G and/or neutrophil elastase that succumb earlier to Staphylococcal and Candida infections, but are competent in ROS production (Reeves et al., 2002).
Neutrophils have been shown to be essential innate effectors in defense against A. fumigatus (Mircescu et al., 2009; Margalit and Kavanagh, 2015). Due to the high mortality rates of neutropenic mice and their inability to control fungal growth and hyphal formation, they are considered to be the most established model of IA (Stephens-Romero et al., 2005; Mircescu et al., 2009). Neutrophils employ various mechanisms in the elimination of A. fumigatus germinating spores such as: ROS generation via NADPH oxidase, lactoferrin production, and through the release of antimicrobial proteases by degranulation (Figure 1; Feldmesser, 2006; Sugui et al., 2007).
The importance of oxidative mediated conidiacidal activity by neutrophils is illustrated in patients suffering from CGD (Grimm et al., 2011). These patients possess mutations in p47phox, which leads to a defective ROS generation by NADPH oxidase (Grimm et al., 2011). In vivo, studies using NADPH oxidase deficient mice as a model for CGD demonstrated delayed recruitment of neutrophils as well as their inability to contain germinating conidia (Bonnett et al., 2006). Histology from the lung tissue samples of the mice showed hyphal structures as well as extensive damage to the lung tissue in contrast to their wild-type counterparts in both C57BL/6 and BALB/C backgrounds (Bonnett et al., 2006). In vitro, the addition of hydrogen peroxide and hypochlorous acid to the NADPH oxidase deficient cells prevented germination indicating the importance of ROS (Bonnett et al., 2006).
Neutrophil extracellular traps (NETs) are extracellular structures that are made of chromatin with proteins from neutrophilic granules attached including neutrophil elastase, myeloperoxidase, cathepsin G, lactoferrin, and gelatinase (Brinkmann et al., 2004). Chromatin is described as the backbone of NETs due to the ability of DNases, but not proteases to degrade it. NETs are formed in response to activation via IL-8, lipopolysaccharide (LPS), bacteria, fungi, or activated platelets (Brinkmann et al., 2004; Brinkmann and Zychlinsky, 2007). Once activated, a subset of neutrophils begin a “suicide” program that leads to the their death and NETosis (Brinkmann and Zychlinsky, 2007). NETs require a respiratory burst, which has been experimentally supported by blocking ROS and preventing NET formation through the use of the oxidase inhibitor diphenylene iodonium (DPI; Brinkmann and Zychlinsky, 2007).
CGD patients, who are more susceptible to IA, have neutrophils that are unable to form NETs when stimulated with bacteria or phorbol myristate acetate (PMA; Brinkmann and Zychlinsky, 2007; Fuchs et al., 2007). The importance of NET formation is controversial, because there is also evidence that neutrophil fungicidal activity is NET-independent (Margalit and Kavanagh, 2015). In vitro, human bronchoalveolar lavage neutrophils treated with micrococcal nuclease (MNase) in order to degrade chromatin and prevent NET formation were still capable of fungicidal activity, which indicates that killing is NET-independent (Bianchi et al., 2009). This observation was further supported by another group that treated neutrophils with cytochalasin-D in order to block phagocytosis, and found that neutrophil killing was abrogated (Bruns et al., 2010). This indicates that phagocytosis and not NET formation is the primary killing mechanism by neutrophils in response to fungi (Bruns et al., 2010). The mechanisms as to whether a neutrophil undergoes NETosis upon contact or phagocytosis of fungal elements remain unclear, but in regards to killing, antimicrobial peptides have been suggested to be one possible mechanism (Levitz et al., 1986; Bruns et al., 2010).
Human neutrophils have also recently been shown to produce NETs in response to A. fumigatus hyphal structures, but to a lesser extent in response to resting and swollen conidia (Bruns et al., 2010). An A. fumigatus mutant that lacks the hydrophobin RodA surface layer of swollen and resting conidia was shown to increase NET formation as compared to wild-type conidia (Bruns et al., 2010). This indicates that a NET inducing element is exposed during hyphal formation when the RodA layer is lost (McCormick et al., 2010). The RodA protein shields the conidia, and prevents the activation of an adaptive immune response (Bruns et al., 2010; McCormick et al., 2010). Another NET associated protein is calprotectin, which has been shown to chelate zinc ions, and inhibit growth of A. fumigatus (McCormick et al., 2010; Bianchi et al., 2011). Addition of zinc ions to culture medium was able to rescue the growth inhibition. (McCormick et al., 2010) The effect seen was not A. fumigatus specific. In vitro, A. nidulans growth was inhibited by blocking calprotectin through S100A9 blocking antibodies or in the S100A9 deficient mouse strain (Bianchi et al., 2011).
Eosinophils and Mast Cells
In ABPA, there is enhanced eosinophil recruitment along with fungal enzymes that have been shown to contribute to epithelial damage. In contrast, there is evidence that eosinophils possess fungicidal activity due to the antimicrobial proteins present in their granules (Patterson and Strek, 2014). Eosinophils have recently been shown to play a role in defense against A. fumigatus (Lilly et al., 2014). Mice deficient in a high-affinity GATA-binding site in the GATA-1 promoter are depleted of eosinophils (not mast cells or platelets) have been shown to have deficiencies in fungal clearance and increase in fungal burden in comparison to their wild-type counterparts (Lilly et al., 2014). In addition, there was impaired production of cytokines and chemokines such as IL-6, IL-17A, GM-CSF, IL-1β, and CXCL1 (Lilly et al., 2014).
Mast cells have been shown to be key mediators of the pathophysiology of asthma (Bradding et al., 2006). They have been shown to localize in the bronchial smooth muscle bundles in patients with severe asthma such as ABPA patients, but not in normal subjects or those with eosinophilic bronchitis (Bradding et al., 2006). Using the RBL-2H3 cell line and bone marrow-derived mast cell cultures to examine mast cell function, A. fumigatus hyphae was shown to adhere to mast cells, and induced their degranulation in an IgE- independent manner unlike conidia and immature hyphae (Urb et al., 2009). Degranulation leads to the release of a variety of enzymatic proteins as well as bioactive substances such as histamine and tryptase, which are important in mediating pulmonary inflammation and airway constriction (Bradding et al., 2006). Although exposure to A.fumigatus leads to degranulation of mast cells, mast cells cannot inhibit their growth or metabolic activity (Urb et al., 2009).
Platelets
Several studies have examined the role of platelets in A. fumigatus infection since development of IA leads to hyphal invasion of blood vessels, which can cause thrombosis as well as vascular infarction (Lopes Bezerra and Filler, 2004). In vitro, it has been shown that human platelets surround and adhere to hyphal structures as well as conidia, but are unable to phagocytose fungal spores (Christin et al., 1998). In contrast, other studies have indicated that it is A. fumigatus-derived serine proteases as well as gliotoxin that lead to platelet activation, and is not contact dependent (Speth et al., 2013). Platelet activation is characterized by the expression of CD62P and CD63 on the cell surface, which are released by α-granules and δ- granules (Perkhofer et al., 2008; Rødland et al., 2010). Platelets incubated with fluorescein isothiocyanate-labeled cell walls lead to the loss of hyphal surface proteins and hyphal cell wall integrity as indicated by the loss of fluorescence via microscopy (Rødland et al., 2010). These results indicate a role for platelets in fungal containment by their ability to damage the fungal cell wall upon exposure through the release platelet microbicidal proteins stored in their granules.
Natural Killer (NK) Cells
Natural Killer (NK) cells have been found to have fungicidal activity, but the mechanisms in which this occurs, are poorly understood (Bouzani et al., 2011; Schmidt et al., 2011, 2013). NK cells have been shown to be responsive to germinating but not resting conidia, and their release of perforins in vitro correlated with increased fungicidal activity (Schmidt et al., 2011). IFNγ produced by NK cells could also contribute to fungal clearance by preventing germinating conidia from growing into hyphal structures, which suggests that in addition to functioning as an immunoregulatory molecule, IFNγ can function as an antifungal effector against A. fumigatus directly (Park et al., 2009; Bouzani et al., 2011). AMs incubated with NK cells in vitro have also been shown to be more effective in killing the conidia than when incubated alone or with IFNγ deficient NK cells. (Park et al., 2009) In neutropenic models that have been depleted of NK cells, the mortality rate is doubled in comparison to neutrophil depleted mice with wild-type NK cell function further suggesting a contribution of NK cells to antifungal defense in vivo (Morrison et al., 2003). Although NK cells have been found to have antifungal activity, they do not seem to be essential. In our previous work, mice that lack all lymphocytes including NK cells, T cells, B cells, γδ T cells, iNKT cells, and innate lymphocytes (ILCs), RAG−∕− γC−∕−, do not develop IA upon infection (Espinosa et al., 2014). These results indicate that these lymphocytes are not required for defense against A. fumigatus infection.
Dendritic Cells (DCs)
Dendritic Cells (DCs) have been shown to have multiple roles in response to A. fumigatus infection (Bhatia et al., 2011) (Table 1). DCs phagocytose conidia through PRRs including Dectin-1, Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN), complement receptor 3 (CR3), and FcγRIII (Bozza et al., 2002; Serrano-Gómez et al., 2005; Mezger et al., 2008). DCs also produce proinflammatory cytokines such as TNFα, IL-6, IL-12, IL-1α, and IL-1β in response to A. fumigatus (Bozza et al., 2002; Mezger et al., 2008; Morton et al., 2011). Differential cytokine production by DCs is observed when exposed to different forms of the fungus in vitro (Bozza et al., 2002). When exposed to conidia and hyphae, TNFα is produced. IL-12 is produced in response to conidia, and IL-4 and IL-10 in response to hyphae (Bozza et al., 2002). There are three major subtypes of DCs in the lung, conventional DCs (cDCs), plasmacytoid DCs (pDCs), and monocyte-derived DCs (moDCs; Margalit and Kavanagh, 2015).
DCs also produce a variety of chemokines that are needed for the recruitment of a variety of innate and adaptive effector cells to aid in fungal elimination (Scapini et al., 2000; Gafa et al., 2007). DCs are recruited to sites of infection by the production of MIP-1α and MIP-1β by neutrophils (Scapini et al., 2000). In vitro, infection of human dendritic cells by A. fumigatus conidia triggers the secretion of chemokines for neutrophil and Th1 lymphocyte recruitment (Gafa et al., 2007). DCs release increased amounts of CXCL8, which results in neutrophil recruitment (Gafa et al., 2007). A. fumigatus infection resulted also in CCL3, CCL4, CXCL10, and CCL20 productions that induce the migration of effector memory Th1 cells (Gafa et al., 2007; Morton et al., 2011). Together these results indicate a dual role for DCs in the innate as well as adaptive immune response against A. fumigatus (Margalit and Kavanagh, 2015).
Plasmacytoid Dendritic Cells (PDCs)
pDCs are known as Type I IFN producing cells in response to viral stimulation. They comprise about 0.2–0.8% of total peripheral blood mononuclear cells (PBMCs) in humans, and express TLRs 7 and 9 (Colonna et al., 2004). pDCs link the innate and adaptive immune systems by secreting IFNα and TNFα, and by differentiating into mature pDCs with upregulated major histocompatilibility complex (MHC) and costimulatory molecules capable of priming naive T cells (Colonna et al., 2004).
pDCs are a major source of type I IFN, but the role of pDCs as well as type I IFN has not been extensively examined in regards to fungal infections (Ramirez-Ortiz et al., 2011; Margalit and Kavanagh, 2015). Interferon αβ receptor deficient mice (IFNAR−∕−) have been shown to have a higher susceptibility to IA in comparison to wild-type mice, which is consistent with the finding that antibody (120G8) mediated depletion of pDCs make mice more vulnerable to A. fumigatus infection (Ramirez-Ortiz et al., 2011). When exposed to hyphae of A. fumigatus, human pDCs inhibited their growth, but did not kill the fungus (Ramirez-Ortiz et al., 2011). In addition, there are contrasting studies as to whether pDCs are capable of engulfing A. fumigatus conidia, which could be attributed to differences in experimental design for pDC isolation such as using CD303 as a marker for positive selection compared to CD123 (Ramirez-Ortiz et al., 2011; Lother et al., 2014). Apoptosis of pDCs is stimulated upon exposure to the release of cytotoxic molecules by A. fumigatus such as gliotoxin, and their death results in the release of antifungal effector molecules such as zinc chelators like calprotectin and iron-binding proteins like lactoferrin (Ramirez-Ortiz et al., 2011). Similar to neutrophils, pDCs have also recently been shown to form Dectin-2 mediated extracellular traps or pETs (plasmacytoid extracellular traps), which have been observed to form around A. fumigatus hyphae (Loures et al., 2015). Treatment with blocking antibodies against Dectin-2 led to decreased association of pDCs with hyphae in contrast to Dectin-1, which was similar to untreated pDCs exposed to A. fumigatus only (Loures et al., 2015). These results suggest that pDCs can recognize A. fumigatus via Dectin-2, which results in antifungal activity through pET formation.
Conventional Dendritic Cells (CDCş)
cDCs as well as moDCs are typically identified by their high expression of the integrin CD11c and MHC class II. There are two types of cDCs: CD103+ cDCs and CD11b+ cDCs (Kopf et al., 2015). They can be distinguished from each other by the markers CD207 (present on CD103+ cDCs) and MER proto-oncogene tyrosine kinase (MerTK; present on CD11b+ cDCs; Kopf et al., 2015). CD11b+ cDCs share common markers with moDCs, but can be differentiated by using the marker for the Fc receptor CD64 that is present on moDCs (Kopf et al., 2015). The development of cDCs as well as pDCs is dependent on the FMS-like tyrosine kinase 3 ligand (Flt3L), which is demonstrated by the lack of CD103+ DCs in Flt3L deficient mice (Ginhoux et al., 2009; Merad et al., 2013). Basic leucine zipper transcription factor ATF-like 3 (BATF3) is also required for their steady-state generation similar to CD8α DCs (Edelson et al., 2010), but under certain inflammatory conditions such as mycobacterial infection, other members of the BATF3 family have been shown to have compensatory roles (Tussiwand et al., 2012). In an allergic asthma house dust mite model, it was demonstrated that moDCs as well as CD11b+ cDCs are important for sensitization, but CD103+ DCs are dispensable (Plantinga et al., 2013). They were able to distinguish the contributions of the difference types of DCs by employing the use of Flt3L deficient mice as well as Langerin- diphtheria toxin receptor (DTR) mice (Plantinga et al., 2013). In Langerin-DTR mice, lung CD103+ DCs and lymphoid tissue CD8α DCs are eliminated (Plantinga et al., 2013).
In a model of invasive aspergillosis, CD103+ DCs were shown to play an important role in shaping a Th17 response through their IL-2 production via nuclear factor of activated T-cells (NFAT) signaling (Zelante et al., 2015). The absence of IL-2 in pulmonary CD103+ DCs led to higher IL-17 production in comparison to T cells cultured with IL-2 competent DCs in vitro in response to A. fumigatus germlings (Zelante et al., 2015). The impact of IL-2 production by DCs was also assessed using mice lacking IL-2 in all tissues or lacking IL-2 in CD4+ T cells as well as mice lacking IL-2 specifically in the CD11c+ population (CD11ccreIL-2fl∕fl; Zelante et al., 2015). Mice deficient in IL-2 in all tissues and in mice lacking IL-2 in CD4+ T cells had significantly higher fungal burden, but had increased survival in comparison to CD11ccre IL-2fl∕fl. CD11ccre IL-2fl∕fl expressed higher levels of IL-17 and IL-23, which led to a fatal hyperinflammatory Th17 response (Zelante et al., 2015). These results indicate that DCs can function as an important regulator of the inflammatory response upon fungal infection.
CCR2+ Inflammatory Monocytes (CCR2+ Mo)
Macrophage and dendritic cell precursors (MDP) in the bone marrow give rise to Ly6Chi monocytes or inflammatory monocytes, which exit the bone marrow in a CC-chemokine receptor 2 (CCR2)- dependent manner in response to infection to the inflamed tissues (Serbina et al., 2008; Geissmann et al., 2010). They represent approximately 2–5% of circulating white blood cells in the bloodstream of a naïve mouse (Shi and Pamer, 2011). The absence of CCR2 leads to deficiencies in monocyte recruitment to the site of infection (Serbina et al., 2008; Shi and Pamer, 2011). CCR2 is also expressed by other cells such as hematopoietic stem cells (HSCs) as well as a subset of NK cells (Si et al., 2010). Once they reach infected tissues, CCR2+ Mo can differentiate into inflammatory macrophages or into TNF and iNOS producing DCs (TIP DCs; Serbina et al., 2003; Auffray et al., 2009; Shi and Pamer, 2011). In the absence of inflammation, CCR2+Mo can return to the bone marrow or to the spleen, which can function as a reservoir for circulating monocytes (Serbina et al., 2008; Geissmann et al., 2010; Shi and Pamer, 2011). Humans also have a similar counterpart, which is characterized by CCR2+ CD14+ CD16− expression (Geissmann et al., 2003).
CCR2 has two primary ligands, CC chemokine ligand 2 (CCL2) and CCL7 that have been shown to be important for monocyte recruitment although the mechanism of action has yet to be fully elucidated (Tsou et al., 2007; Shi and Pamer, 2011). In a theoretical model, it was hypothesized that CC-chemokine ligands establish gradients, which guide monocytes to the site of infection by their association with glycosaminoglycans (Proudfoot et al., 2003; Allen et al., 2007). The finding that amino acid substitutions in CCL2 affected monocyte recruitment supported this idea (Proudfoot et al., 2003). Other CC-chemokine ligands, CCL8 and CCL12, have also been shown to bind to CCR2, but did not have a significant role in monocyte trafficking (Tsou et al., 2007). Migration of monocytes is dependent on various integrin and adhesion molecules such as L-selectin (CD62L), P-selectin glycoprotein ligand 1 (PSGL1), lymphocyte function-associated antigen 1 (LFA1; also known as αLβ2 integrin), macrophage receptor 1 (MAC1; also known as integrin αMβ2), platelet endothelial cell adhesion molecule (PECAM1), and very late antigen 4 (VLA4; also known as integrin α4β1; Ley et al., 2007). These molecules are necessary for proper rolling, adhesion, and migration of CCR2+ Mo to infected tissues by a variety of different pathogens (Ley et al., 2007). CCR2+ Mo have been shown to play important roles in bacterial, viral, protozoan, and fungal infections (Shi and Pamer, 2011).
In the context of A. fumigatus infection our previous studies found an essential role for CCR2+ monocyte-derived dendritic cells in the activation of fungus-specific CD4+ T cells. In these studies, the role of CCR2 was investigated using a depleter mouse strain, in which the CCR2 promoter drives the expression of the simian diphtheria toxin receptor (Hohl et al., 2009). Administration of diphtheria toxin (DT) leads to the transient depletion of monocytes in the blood, bone marrow, and peripheral tissues (Hohl et al., 2009). Depletion of CCR2+ Mo before infection leads to decreased transport of fungal spores to the draining lymph nodes, which prevents A. fumigatus-specific CD4+ T cell priming (Rivera et al., 2011). Depletion of CCR2+ moDCs at later stages of infection, leads to a skewing from a Th1 to a Th17 response in the lung, which indicates that recruitment of monocytes has an influential role in shaping the adaptive immune response and are necessary to promote and sustain Th1 responses (Rivera et al., 2011). Studies with other fungal pathogens further support a conserved function for moDCs in shaping fungus-specific CD4+ T cell responses (Traynor et al., 2002; Szymczak and Deepe, 2009; Ersland et al., 2010; Szymczak and Deepe, 2010; Wüthrich et al., 2012b).
In addition to their importance in shaping fungus-specific CD4+ T cell responses, CCR2+ Mo and moDCs are important direct effectors necessary for prevention of IA (Espinosa et al., 2014). In recent studies, we found that sustained depletion of CCR2+ Mo results in the rapid development of IA. Our studies suggest that CCR2+ Mo and their derivative moDCs are important direct effectors of fungal spore killing. Moreover, they are necessary to sustain an inflammatory milieu in the lung and the antifungal activity of neutrophils (Espinosa et al., 2014; Caffrey et al., 2015). Altogether, these studies indicate that CCR2+ Mo and their derivative moDCs are crucial, non-redundant cells in antifungal defense to A. fumigatus by acting both as direct innate effectors and by shaping the response of other innate and adaptive immune cells. The importance of monocytes in defense against IA is likely conserved in humans. Patients with monocytopenia are at increased risk for fungal infections (Vinh et al., 2010; Hsu et al., 2011). Moreover, CD14+CD16− monocytes isolated from healthy allogeneic hematopoietic stem cell transplantation donors were shown to phagocytose conidia, and inhibit conidial germination while the CD14+CD16+ subset was able to produce cytokines (Serbina et al., 2009).
Concluding Remarks
The detrimental impact of fungal infections to diverse patient populations across the globe is likely to continue to rise. The interactions of fungi with host innate cells crucially determine the outcome of infection with multiple innate cells subsets contributing essential protective functions. Future therapeutic interventions aimed at boosting innate immunity are likely to provide significant benefit and help improve the current detrimental outcomes associated with invasive aspergillosis and other invasive fungal infections.
Author Contributions
The author confirms being the sole contributor of this work and approved it for publication.
Funding
Research in the Rivera lab is supported by the National Institutes of Health under awards granted by National Institute of Allergy and Infectious Diseases R01AI114647-01A1 and National Cancer Institute R21CA167238-01A1 to AR, and fellowship F31 AI098408-01A1 to VE. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Aimanianda, V., Bayry, J., Bozza, S., Kniemeyer, O., Perruccio, K., Elluru, S. R., et al. (2009). Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 460, 1117–1121. doi: 10.1038/nature08264
Alekseeva, L., Huet, D., Femenia, F., Mouyna, I., Abdelouahab, M., Cagna, A., et al. (2009). Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol. 9:33. doi: 10.1186/1471-2180-9-33
Allen, S. J., Crown, S. E., and Handel, T. M. (2007). Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25, 787–820. doi: 10.1146/annurev.immunol.24.021605.090529
Auffray, C., Sieweke, M. H., and Geissmann, F. (2009). Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669–692. doi: 10.1146/annurev.immunol.021908.132557
Balloy, V., and Chignard, M. (2009). The innate immune response to Aspergillus fumigatus. Microbes Infect. 11, 919–927. doi: 10.1016/j.micinf.2009.07.002
Balloy, V., Sallenave, J. M., Wu, Y., Touqui, L., Latge, J. P., Si-Tahar, M., et al. (2008). Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway. J. Biol. Chem. 283, 30513–30521. doi: 10.1074/jbc.M803149200
Bellocchio, S., Moretti, S., Perruccio, K., Fallarino, F., Bozza, S., Montagnoli, C., et al. (2004). TLRs govern neutrophil activity in aspergillosis. J. Immunol. 173, 7406–7715. doi: 10.4049/jimmunol.173.12.7406
Ben-Ami, R., Lewis, R. E., and Kontoyiannis, D. P. (2010). Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br. J. Haematol. 150, 406–417. doi: 10.1111/j.1365-2141.2010.08283.x
Bhatia, S., Fei, M., Yarlagadda, M., Qi, Z., Akira, S., Saijo, S., et al. (2011). Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS ONE 6:e15943. doi: 10.1371/journal.pone.0015943
Bianchi, M., Hakkim, A., Brinkmann, V., Siler, U., Seger, R. A., Zychlinsky, A., et al. (2009). Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 114, 2619–2622. doi: 10.1182/blood-2009-05-221606
Bianchi, M., Niemiec, M. J., Siler, U., Urban, C. F., and Reichenbach, J. (2011). Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J. Allergy Clin. Immunol. 127, 1243–52.e7. doi: 10.1016/j.jaci.2011.01.021
Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M., et al. (1992). Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11, 99–109. doi: 10.1007/BF01967060
Bonnett, C. R., Cornish, E. J., Harmsen, A. G., and Burritt, J. B. (2006). Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia. Infect. Immun. 74, 6528–6539. doi: 10.1128/IAI.00909-06
Bouzani, M., Ok, M., McCormick, A., Ebel, F., Kurzai, O., Morton, C. O., et al. (2011). Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release. J. Immunol. 187, 1369–1376. doi: 10.4049/jimmunol.1003593
Bozza, S., Gaziano, R., Spreca, A., Bacci, A., Montagnoli, C., di Francesco, P., et al. (2002). Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J. Immunol. 168, 1362–1171. doi: 10.4049/jimmunol.168.3.1362
Bradding, P., Walls, A. F., and Holgate, S. T. (2006). The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117, 1277–1284. doi: 10.1016/j.jaci.2006.02.039
Bretz, C., Gersuk, G., Knoblaugh, S., Chaudhary, N., Randolph-Habecker, J., Hackman, R. C., et al. (2008). MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus. Infect. Immun. 76, 952–958. doi: 10.1128/IAI.00927-07
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., et al. (2004). Neutrophil extracellular traps kill bacteria. Science 303, 1532–1535. doi: 10.1126/science.1092385
Brinkmann, V., and Zychlinsky, A. (2007). Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 5, 577–582. doi: 10.1038/nrmicro1710
Brown, G. D., Denning, D. W., Gow, N. A., Levitz, S. M., Netea, M. G., and White, T. C. (2012). Hidden killers: human fungal infections. Sci. Transl. Med. 4, 165rv13. doi: 10.1126/scitranslmed.3004404
Bruns, S., Kniemeyer, O., Hasenberg, M., Aimanianda, V., Nietzsche, S., Thywissen, A., et al. (2010). Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog. 6:e1000873. doi: 10.1371/journal.ppat.1000873
Caffrey, A. K., Lehmann, M. M., Zickovich, J. M., Espinosa, V., Shepardson, K. M., Watschke, C. P., et al. (2015). IL-1alpha signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge. PLoS Pathog. 11:e1004625. doi: 10.1371/journal.ppat.1004625
Carvalho, A., De Luca, A., Bozza, S., Cunha, C., D'Angelo, C., Moretti, S., et al. (2012). TLR3 essentially promotes protective class I-restricted memory CD8(+) T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood 119, 967–977. doi: 10.1182/blood-2011-06-362582
Christin, L., Wysong, D. R., Meshulam, T., Hastey, R., Simons, E. R., and Diamond, R. D. (1998). Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect. Immun. 66, 1181–1189.
Cockrill, B. A., and Hales, C. A. (1999). Allergic bronchopulmonary aspergillosis. Annu. Rev. Med. 50, 303–316. doi: 10.1146/annurev.med.50.1.303
Colonna, M., Trinchieri, G., and Liu, Y. J. (2004). Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219–1226. doi: 10.1038/ni1141
Dagenais, T. R., and Keller, N. P. (2009). Pathogenesis of Aspergillus fumigatus in invasive Aspergillosis. Clin. Microbiol. Rev. 22, 447–465. doi: 10.1128/CMR.00055-08
de Luca, A., Bozza, S., Zelante, T., Zagarella, S., D'Angelo, C., Perruccio, K., et al. (2010). Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell. Mol. Immunol. 7, 459–470. doi: 10.1038/cmi.2010.43
Dixon, D. M., McNeil, M. M., Cohen, M. L., Gellin, B. G., and La Montagne, J. R. (1996). Fungal infections: a growing threat. Public Health Rep. 111, 226–235.
Dubourdeau, M., Athman, R., Balloy, V., Huerre, M., Chignard, M., Philpott, D. J., et al. (2006). Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4. J. Immunol. 177, 3994–4001. doi: 10.4049/jimmunol.177.6.3994
Edelson, B. T., Kc, W., Juang, R., Kohyama, M., Benoit, L. A., Klekotka, P. A., et al. (2010). Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 207, 823–836. doi: 10.1084/jem.20091627
Ersland, K., Wüthrich, M., and Klein, B. S. (2010). Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi. Cell Host Microbe 7, 474–487. doi: 10.1016/j.chom.2010.05.010
Espinosa, V., Jhingran, A., Dutta, O., Kasahara, S., Donnelly, R., Du, P., et al. (2014). Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog. 10:e1003940. doi: 10.1371/journal.ppat.1003940
Fallon, J. P., Reeves, E. P., and Kavanagh, K. (2010). Inhibition of neutrophil function following exposure to the Aspergillus fumigatus toxin fumagillin. J. Med. Microbiol. 59(Pt 6), 625–633. doi: 10.1099/jmm.0.018192-0
Faro-Trindade, I., Willment, J. A., Kerrigan, A. M., Redelinghuys, P., Hadebe, S., Reid, D. M., et al. (2012). Characterisation of innate fungal recognition in the lung. PLoS ONE 7:e35675. doi: 10.1371/journal.pone.0035675
Feldmesser, M. (2006). Role of neutrophils in invasive aspergillosis. Infect. Immun. 74, 6514–6516. doi: 10.1128/IAI.01551-06
Filler, S. G., and Sheppard, D. C. (2006). Fungal invasion of normally non-phagocytic host cells. PLoS Pathog. 2:e129. doi: 10.1371/journal.ppat.0020129
Forman, H. J., and Torres, M. (2002). Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166(12 Pt 2), S4–S8. doi: 10.1164/rccm.2206007
Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., et al. (2007). Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231–241. doi: 10.1083/jcb.200606027
Fujimura, M., Ishiura, Y., Kasahara, K., Amemiya, T., Myou, S., Hayashi, Y., et al. (1998). Necrotizing bronchial aspergillosis as a cause of hemoptysis in sarcoidosis. Am. J. Med. Sci. 315, 56–58.
Gafa, V., Remoli, M. E., Giacomini, E., Gagliardi, M. C., Lande, R., Severa, M., et al. (2007). In vitro infection of human dendritic cells by Aspergillus fumigatus conidia triggers the secretion of chemokines for neutrophil and Th1 lymphocyte recruitment. Microb. Infect. 9, 971–980. doi: 10.1016/j.micinf.2007.03.015
Geissmann, F., Jung, S., and Littman, D. R. (2003). Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71–82. doi: 10.1016/S1074-7613(03)00174-2
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., and Ley, K. (2010). Development of monocytes, macrophages, and dendritic cells. Science 327, 656–661. doi: 10.1126/science.1178331
Gersuk, G. M., Underhill, D. M., Zhu, L., and Marr, K. A. (2006). Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J. Immunol. 176, 3717–3724. doi: 10.4049/jimmunol.176.6.3717
Ginhoux, F., Liu, K., Helft, J., Bogunovic, M., Greter, M., Hashimoto, D., et al. (2009). The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206, 3115–3130. doi: 10.1084/jem.20091756
Grimm, M. J., Vethanayagam, R. R., Almyroudis, N. G., Dennis, C. G., Khan, A. N., D'Auria, A. C., et al. (2013). Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. J. Immunol. 190, 4175–4184. doi: 10.4049/jimmunol.1202800
Grimm, M. J., Vethanayagam, R. R., Almyroudis, N. G., Lewandowski, D., Rall, N., Blackwell, T. S., et al. (2011). Role of NADPH oxidase in host defense against aspergillosis. Med. Mycol. 49(Suppl. 1), S144–S149. doi: 10.3109/13693786.2010.487077
Hohl, T. M., and Feldmesser, M. (2007). Aspergillus fumigatus: principles of pathogenesis and host defense. Eukaryotic Cell 6, 1953–1963. doi: 10.1128/EC.00274-07
Hohl, T. M., Rivera, A., Lipuma, L., Gallegos, A., Shi, C., Mack, M., et al. (2009). Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 6, 470–481. doi: 10.1016/j.chom.2009.10.007
Hohl, T. M., Van Epps, H. L., Rivera, A., Morgan, L. A., Chen, P. L., Feldmesser, M., et al. (2005). Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog. 1:e30. doi: 10.1371/journal.ppat.0010030
Horng, T., Barton, G. M., Flavell, R. A., and Medzhitov, R. (2002). The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329–333. doi: 10.1038/nature01180
Hsu, A. P., Sampaio, E. P., Khan, J., Calvo, K. R., Lemieux, J. E., Patel, S. Y., et al. (2011). Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118, 2653–2655. doi: 10.1182/blood-2011-05-356352
Ibrahim-Granet, O., Philippe, B., Boleti, H., Boisvieux-Ulrich, E., Grenet, D., Stern, M., et al. (2003). Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect. Immun. 71, 891–903. doi: 10.1128/IAI.71.2.891-903.2003
Jhingran, A., Kasahara, S., Shepardson, K. M., Junecko, B. A., Heung, L. J., Kumasaka, D. K., et al. (2015). Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection. PLoS Pathog. 11:e1004589. doi: 10.1371/journal.ppat.1004589
Kaiser, L., Huguenin, T., Lew, P. D., Chapuis, B., and Pittet, D. (1998). Invasive aspergillosis. Clinical features of 35 proven cases at a single institution. Medicine (Baltimore). 77, 188–194. doi: 10.1097/00005792-199805000-00004
Kasperkovitz, P. V., Cardenas, M. L., and Vyas, J. M. (2010). TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking. J. Immunol. 185, 7614–7622. doi: 10.4049/jimmunol.1002760
Kawai, T., and Akira, S. (2007). TLR signaling. Semin. Immunol. 19, 24–32. doi: 10.1016/j.smim.2006.12.004
Kirsten, D., Rieger, U., Amthor, M., and Magnussen, H. (1992). [Invasive aspergillosis in cavitary lung sarcoidosis]. Pneumologie 46, 239–242.
Knutsen, A. P., Bellone, C., and Kauffman, H. (2002). Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis. J. Cyst. Fibros. 1, 76–89. doi: 10.1016/S1569-1993(02)00033-4
Knutsen, A., and Slavin, R. G. (1992). Allergic bronchopulmonary mycosis complicating cystic fibrosis. Semin. Respir. Infect. 7, 179–192.
Kopf, M., Schneider, C., and Nobs, S. P. (2015). The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16, 36–44. doi: 10.1038/ni.3052
Lehrnbecher, T., Frank, C., Engels, K., Kriener, S., Groll, A. H., and Schwabe, D. (2010). Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 61, 259–265. doi: 10.1016/j.jinf.2010.06.018
Levitz, S. M. (2010). Innate recognition of fungal cell walls. PLoS Pathog. 6:e1000758. doi: 10.1371/journal.ppat.1000758
Levitz, S. M., Selsted, M. E., Ganz, T., Lehrer, R. I., and Diamond, R. D. (1986). In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis. 154, 483–489. doi: 10.1093/infdis/154.3.483
Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678–689. doi: 10.1038/nri2156
Lilly, L. M., Scopel, M., Nelson, M. P., Burg, A. R., Dunaway, C. W., and Steele, C. (2014). Eosinophil deficiency compromises lung defense against Aspergillus fumigatus. Infect. Immun. 82, 1315–1325. doi: 10.1128/IAI.01172-13
Lopes Bezerra, L. M., and Filler, S. G. (2004). Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity. Blood 103, 2143–2149. doi: 10.1182/blood-2003-06-2186
Lother, J., Breitschopf, T., Krappmann, S., Morton, C. O., Bouzani, M., Kurzai, O., et al. (2014). Human dendritic cell subsets display distinct interactions with the pathogenic mould Aspergillus fumigatus. Int. J. Med. Microbiol. 304, 1160–1168. doi: 10.1016/j.ijmm.2014.08.009
Loures, F. V., Röhm, M., Lee, C. K., Santos, E., Wang, J. P., Specht, C. A., et al. (2015). Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps. PLoS Pathog. 11:e1004643. doi: 10.1371/journal.ppat.1004643
Luther, K., Torosantucci, A., Brakhage, A. A., Heesemann, J., and Ebel, F. (2007). Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell. Microbiol. 9, 368–381. doi: 10.1111/j.1462-5822.2006.00796.x
Margalit, A., and Kavanagh, K. (2015). The innate immune response to Aspergillus fumigatus at the alveolar surface. FEMS Microbiol. Rev. 39, 670–687. doi: 10.1093/femsre/fuv018
McCormick, A., Heesemann, L., Wagener, J., Marcos, V., Hartl, D., Loeffler, J., et al. (2010). NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect. 12, 928–936. doi: 10.1016/j.micinf.2010.06.009
Meier, A., Kirschning, C. J., Nikolaus, T., Wagner, H., Heesemann, J., and Ebel, F. (2003). Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell. Microbiol. 5, 561–570. doi: 10.1046/j.1462-5822.2003.00301.x
Merad, M., Sathe, P., Helft, J., Miller, J., and Mortha, A. (2013). The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563–604. doi: 10.1146/annurev-immunol-020711-074950
Mezger, M., Kneitz, S., Wozniok, I., Kurzai, O., Einsele, H., and Loeffler, J. (2008). Proinflammatory response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes. J. Infect. Dis. 197, 924–931. doi: 10.1086/528694
Mircescu, M. M., Lipuma, L., van Rooijen, N., Pamer, E. G., and Hohl, T. M. (2009). Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J. Infect. Dis. 200, 647–656. doi: 10.1086/600380
Morrison, B. E., Park, S. J., Mooney, J. M., and Mehrad, B. (2003). Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J. Clin. Invest. 112, 1862–1870. doi: 10.1172/JCI18125
Morton, C. O., Varga, J. J., Hornbach, A., Mezger, M., Sennefelder, H., Kneitz, S., et al. (2011). The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro. PLoS ONE 6:e16016. doi: 10.1371/journal.pone.0016016
Moss, R. B. (2002). Allergic bronchopulmonary aspergillosis. Clin. Rev. Allergy Immunol. 23, 87–104. doi: 10.1385/CRIAI:23:1:087
Moss, R. B. (2005). Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. Med. Mycol. 43(Suppl. 1), S203–S206. doi: 10.1080/13693780500052255
Paris, S., Boisvieux-Ulrich, E., Crestani, B., Houcine, O., Taramelli, D., Lombardi, L., et al. (1997). Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells. Infect. Immun. 65, 1510–1514.
Park, S. J., Hughes, M. A., Burdick, M., Strieter, R. M., and Mehrad, B. (2009). Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J. Immunol. 182, 4306–4312. doi: 10.4049/jimmunol.0803462
Patterson, K. C., and Strek, M. E. (2014). Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest 146, 1358–1368. doi: 10.1378/chest.14-0917
Perkhofer, S., Kehrel, B. E., Dierich, M. P., Donnelly, J. P., Nussbaumer, W., Hofmann, J., et al. (2008). Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J. Infect. Dis. 198, 1243–1246. doi: 10.1086/591458
Philippe, B., Ibrahim-Granet, O., Prévost, M. C., Gougerot-Pocidalo, M. A., Sanchez Perez, M. A., Van der Meeren, A., et al. (2003). Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect. Immun. 71, 3034–3042. doi: 10.1128/IAI.71.6.3034-3042.2003
Plantinga, M., Guilliams, M., Vanheerswynghels, M., Deswarte, K., Branco-Madeira, F., Toussaint, W., et al. (2013). Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38, 322–335. doi: 10.1016/j.immuni.2012.10.016
Proudfoot, A. E., Handel, T. M., Johnson, Z., Lau, E. K., LiWang, P., Clark-Lewis, I., et al. (2003). Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U.S.A. 100, 1885–1890. doi: 10.1073/pnas.0334864100
Ramaprakash, H., Ito, T., Standiford, T. J., Kunkel, S. L., and Hogaboam, C. M. (2009). Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice. Infect. Immun. 77, 108–119. doi: 10.1128/IAI.00998-08
Ramirez-Ortiz, Z. G., Lee, C. K., Wang, J. P., Boon, L., Specht, C. A., and Levitz, S. M. (2011). A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe 9, 415–424. doi: 10.1016/j.chom.2011.04.007
Ramirez-Ortiz, Z. G., Specht, C. A., Wang, J. P., Lee, C. K., Bartholomeu, D. C., Gazzinelli, R. T., et al. (2008). Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DN. Infect. Immun. A 76, 2123–2129. doi: 10.1128/IAI.00047-08
Reeves, E. P., Lu, H., Jacobs, H. L., Messina, C. G., Bolsover, S., Gabella, G., et al. (2002). Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416, 291–297. doi: 10.1038/416291a
Rivera, A. (2014). Protective immune responses to fungal infections. Parasite Immunol. 36, 453–462. doi: 10.1111/pim.12098
Rivera, A., Hohl, T. M., Collins, N., Leiner, I., Gallegos, A., Saijo, S., et al. (2011). Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J. Exp. Med. 208, 369–381. doi: 10.1084/jem.20100906
Rødland, E. K., Ueland, T., Pedersen, T. M., Halvorsen, B., Muller, F., Aukrust, P., et al. (2010). Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis. Infect. Immun. 78, 1269–1275. doi: 10.1128/IAI.01091-09
Rubino, I., Coste, A., Le Roy, D., Roger, T., Jaton, K., Boeckh, M., et al. (2012). Species-specific recognition of Aspergillus fumigatus by Toll-like receptor 1 and Toll-like receptor 6. J. Infect. Dis. 205, 944–954. doi: 10.1093/infdis/jir882
Scapini, P., Lapinet-Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F., and Cassatella, M. A. (2000). The neutrophil as a cellular source of chemokines. Immunol. Rev. 177, 195–203. doi: 10.1034/j.1600-065X.2000.17706.x
Schmidt, S., Tramsen, L., Hanisch, M., Latge, J. P., Huenecke, S., Koehl, U., et al. (2011). Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J. Infect. Dis. 203, 430–435. doi: 10.1093/infdis/jiq062
Schmidt, S., Zimmermann, S. Y., Tramsen, L., Koehl, U., and Lehrnbecher, T. (2013). Natural killer cells and antifungal host response. Clin. Vaccine Immunol. 20, 452–458. doi: 10.1128/CVI.00606-12
Segal, A. W. (2005). How neutrophils kill microbes. Annu. Rev. Immunol. 23, 197–223. doi: 10.1146/annurev.immunol.23.021704.115653
Segal, A. W., and Jones, O. T. (1979). The subcellular distribution and some properties of the cytochrome b component of the microbicidal oxidase system of human neutrophils. Biochem. J. 182, 181–188. doi: 10.1042/bj1820181
Serbina, N. V., Cherny, M., Shi, C., Bleau, S. A., Collins, N. H., Young, J. W., et al. (2009). Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. J. Immunol. 183, 2678–2687. doi: 10.4049/jimmunol.0803398
Serbina, N. V., Jia, T., Hohl, T. M., and Pamer, E. G. (2008). Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26, 421–452. doi: 10.1146/annurev.immunol.26.021607.090326
Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A., and Pamer, E. G. (2003). TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19, 59–70. doi: 10.1016/S1074-7613(03)00171-7
Serrano-Gómez, D., Leal, J. A., and Corbí, A. L. (2005). DC-SIGN mediates the binding of Aspergillus fumigatus and keratinophylic fungi by human dendritic cells. Immunobiology 210, 175–183. doi: 10.1016/j.imbio.2005.05.011
Shi, C., and Pamer, E. G. (2011). Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11, 762–774. doi: 10.1038/nri3070
Si, Y., Tsou, C. L., Croft, K., and Charo, I. F. (2010). CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J. Clin. Invest. 120, 1192–1203. doi: 10.1172/JCI40310
Speth, C., Hagleitner, M., Ott, H. W., Würzner, R., Lass-Flörl, C., and Rambach, G. (2013). Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds. J. Infect. Dis. 207, 823–833. doi: 10.1093/infdis/jis743
Spikes, S., Xu, R., Nguyen, C. K., Chamilos, G., Kontoyiannis, D. P., Jacobson, R. H., et al. (2008). Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J. Infect. Dis. 197, 479–486. doi: 10.1086/525044
Spitznagel, J. K. (1990). Antibiotic proteins of human neutrophils. J. Clin. Invest. 86, 1381–1386. doi: 10.1172/JCI114851
Steele, C., Rapaka, R. R., Metz, A., Pop, S. M., Williams, D. L., Gordon, S., et al. (2005). The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. 1:e42. doi: 10.1371/journal.ppat.0010042
Stephens-Romero, S. D., Mednick, A. J., and Feldmesser, M. (2005). The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect. Immun. 73, 114–125. doi: 10.1128/IAI.73.1.114-125.2005
Sugui, J. A., Pardo, J., Chang, Y. C., Zarember, K. A., Nardone, G., Galvez, E. M., et al. (2007). Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryotic Cell 6, 1562–1569. doi: 10.1128/EC.00141-07
Sun, H., Xu, X. Y., Shao, H. T., Su, X., Wu, X. D., Wang, Q., et al. (2013). Dectin-2 is predominately macrophage restricted and exhibits conspicuous expression during Aspergillus fumigatus invasion in human lung. Cell. Immunol. 284, 60–67. doi: 10.1016/j.cellimm.2013.06.013
Sun, H., Xu, X. Y., Tian, X. L., Shao, H. T., Wu, X. D., Wang, Q., et al. (2014). Activation of NF-kappaB and respiratory burst following Aspergillus fumigatus stimulation of macrophages. Immunobiology 219, 25–36. doi: 10.1016/j.imbio.2013.06.013
Sun, W. K., Lu, X., Li, X., Sun, Q. Y., Su, X., Song, Y., et al. (2012). Dectin-1 is inducible and plays a crucial role in Aspergillus-induced innate immune responses in human bronchial epithelial cells. Eur. J. Clin. Microbiol. Infect. Dis. 31, 2755–2764. doi: 10.1007/s10096-012-1624-8
Szymczak, W. A., and Deepe, G. S. Jr. (2010). Antigen-presenting dendritic cells rescue CD4-depleted CCR2-/- mice from lethal Histoplasma capsulatum infection. Infect. Immun. 78, 2125–2137. doi: 10.1128/IAI.00065-10
Szymczak, W. A., and Deepe, G. S. Jr. (2009). The CCL7-CCL2-CCR2 axis regulates, IL-4 production in lungs and fungal immunity. J. Immunol. 183, 1964–1974. doi: 10.4049/jimmunol.0901316
Takeda, K., and Akira, S. (2005). Toll-like receptors in innate immunity. Int. Immunol. 17, 1–14. doi: 10.1093/intimm/dxh186
Traynor, T. R., Herring, A. C., Dorf, M. E., Kuziel, W. A., Toews, G. B., and Huffnagle, G. B. (2002). Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J. Immunol. 168, 4659–4666. doi: 10.4049/jimmunol.168.9.4659
Tsou, C. L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., et al. (2007). Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902–909. doi: 10.1172/JCI29919
Tsunawaki, S., Yoshida, L. S., Nishida, S., Kobayashi, T., and Shimoyama, T. (2004). Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect. Immun. 72, 3373–3382. doi: 10.1128/IAI.72.6.3373-3382.2004
Tussiwand, R., Lee, W. L., Murphy, T. L., Mashayekhi, M., Kc, W., Albring, J. C., et al. (2012). Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490, 502–507. doi: 10.1038/nature11531
Urb, M., Pouliot, P., Gravelat, F. N., Olivier, M., and Sheppard, D. C. (2009). Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. J. Infect. Dis. 200, 464–472. doi: 10.1086/600070
Verma, A., Wüthrich, M., Deepe, G., and Klein, B. (2015). Adaptive immunity to fungi. Cold Spring Harb. Perspect. Med. 5:a019612. doi: 10.1101/cshperspect.a019612
Vinh, D. C., Patel, S. Y., Uzel, G., Anderson, V. L., Freeman, A. F., Olivier, K. N., et al. (2010). Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 115, 1519–1529. doi: 10.1182/blood-2009-03-208629
Wald, A., Leisenring, W., van Burik, J. A., and Bowden, R. A. (1997). Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175, 1459–1466. doi: 10.1086/516480
Wasylnka, J. A., and Moore, M. M. (2003). Aspergillus fumigatus conidia survive and germinate in acidic organelles of A549 epithelial cells. J. Cell Sci. 116(Pt 8), 1579–1587. doi: 10.1242/jcs.00329
Werner, J. L., Metz, A. E., Horn, D., Schoeb, T. R., Hewitt, M. M., Schwiebert, L. M., et al. (2009). Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 182, 4938–4946. doi: 10.4049/jimmunol.0804250
Wuthrich, M., Deepe, G. S. Jr., and Klein, B. (2012a). Adaptive immunity to fungi. Annu. Rev. Immunol. 30, 115–148. doi: 10.1146/annurev-immunol-020711-074958
Wüthrich, M., Ersland, K., Sullivan, T., Galles, K., and Klein, B. S. (2012b). Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes. Immunity 36, 680–692. doi: 10.1016/j.immuni.2012.02.015
Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., et al. (2003). TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144–1150. doi: 10.1038/ni986
Keywords: aspergillosis, innate cells, monocytes subsets, mechanisms of resistance, neutrophils, dendritic cells (DC)
Citation: Espinosa V and Rivera A (2016) First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis. Front. Microbiol. 7:272. doi: 10.3389/fmicb.2016.00272
Received: 30 November 2015; Accepted: 19 February 2016;
Published: 03 March 2016.
Edited by:
Hector Mora Montes, Universidad de Guanajuato, MexicoReviewed by:
Julian Naglik, King's College London, UKSven Krappmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Germany
Copyright © 2016 Espinosa and Rivera. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Amariliz Rivera, cml2ZXJhYW1Abmptcy5ydXRnZXJzLmVkdQ==